Your browser doesn't support javascript.
loading
Extended-synaptotagmin 1 engages in unconventional protein secretion mediated via SEC22B+ vesicle pathway in liver cancer.
Yamada, Kohji; Motohashi, Saya; Oikawa, Tsunekazu; Tago, Naoko; Koizumi, Rei; Ono, Masaya; Tachibana, Toshiaki; Yoshida, Ayano; Yoshida, Saishu; Shimoda, Masayuki; Oka, Masahiro; Yoneda, Yoshihiro; Yoshida, Kiyotsugu.
  • Yamada K; Department of Biochemistry, Jikei University School of Medicine, Tokyo 105-8461, Japan.
  • Motohashi S; Department of Biochemistry, Jikei University School of Medicine, Tokyo 105-8461, Japan.
  • Oikawa T; Division of Gastroenterology and Hepatology, Department of Internal Medicine, Jikei University School of Medicine, Tokyo 105-8461, Japan.
  • Tago N; Department of Biochemistry, Jikei University School of Medicine, Tokyo 105-8461, Japan.
  • Koizumi R; Department of Biochemistry, Jikei University School of Medicine, Tokyo 105-8461, Japan.
  • Ono M; Department of Clinical Proteomics, National Cancer Center Research Institute, Tokyo 104-0045, Japan.
  • Tachibana T; Core Research Facilities for Basic Science, Research Center for Medical Sciences, Jikei University School of Medicine, Tokyo 105-8461, Japan.
  • Yoshida A; Department of Biochemistry, Jikei University School of Medicine, Tokyo 105-8461, Japan.
  • Yoshida S; Department of Biochemistry, Jikei University School of Medicine, Tokyo 105-8461, Japan.
  • Shimoda M; Department of Pathology, Jikei University School of Medicine, Tokyo 105-8461, Japan.
  • Oka M; Laboratory of Nuclear Transport Dynamics, National Institutes of Biomedical Innovation, Health and Nutrition, Osaka 567-0085, Japan.
  • Yoneda Y; National Institutes of Biomedical Innovation, Health and Nutrition, Osaka 567-0085, Japan.
  • Yoshida K; Department of Biochemistry, Jikei University School of Medicine, Tokyo 105-8461, Japan.
Proc Natl Acad Sci U S A ; 119(36): e2202730119, 2022 09 06.
Article en En | MEDLINE | ID: mdl-36044553
ABSTRACT
Protein secretion in cancer cells defines tumor survival and progression by orchestrating the microenvironment. Studies suggest the occurrence of active secretion of cytosolic proteins in liver cancer and their involvement in tumorigenesis. Here, we investigated the identification of extended-synaptotagmin 1 (E-Syt1), an endoplasmic reticulum (ER)-bound protein, as a key mediator for cytosolic protein secretion at the ER-plasma membrane (PM) contact sites. Cytosolic proteins interacted with E-Syt1 on the ER, and then localized spatially inside SEC22B+ vesicles of liver cancer cells. Consequently, SEC22B on the vesicle tethered to the PM via Q-SNAREs (SNAP23, SNX3, and SNX4) for their secretion. Furthermore, inhibiting the interaction of protein kinase Cδ (PKCδ), a liver cancer-specific secretory cytosolic protein, with E-Syt1 by a PKCδ antibody, decreased in both PKCδ secretion and tumorigenicity. Results reveal the role of ER-PM contact sites in cytosolic protein secretion and provide a basis for ER-targeting therapy for liver cancer.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sinaptotagmina I / Proteínas R-SNARE / Neoplasias Hepáticas Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sinaptotagmina I / Proteínas R-SNARE / Neoplasias Hepáticas Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article